Literature DB >> 221900

Avian acute leukemia viruses MC29 and MH2 share specific RNA sequences: evidence for a second class of transforming genes.

P H Duesberg, P K Vogt.   

Abstract

The genome of the defective avian tumor virus MH2 was identified as a RNA of 5.7 kilobases by its presence in different MH2-helper virus complexes and its absence from pure helper virus, by its unique fingerprint pattern of RNase T1-resistant (T1) oligonucleotides that differed from those of two helper virus RNAs, and by its structural analogy to the RNA of MC29, another avian acute leukemia virus. Two sets of sequences were distinguished in MH2 RNA: 66% hybridized with DNA complementary to helper-independent avian tumor viruses, termed group-specific, and 34% were specific. The percentage of specific sequences is considered a minimal estimate because the MH2 RNA used was about 30% contaminated by helper virus RNA. No sequences related to the transforming src gene of avian sarcoma viruses were found in MH2. MH2 shared three large T1 oligonucleotides with MC29, two of which could also be isolated from a RNase A- and T1-resistant hybrid formed between MH2 RNA and MC29 specific cDNA. These oligonucleotides belong to a group of six that define the specific segment of MC29 RNA described previously. The group-specific sequences of MH2 and MC29 RNA shared only the two smallest out of about 20 T1 oligonucleotides associated with MH2 RNA. It is concluded that the specific sequences of MH2 and MC29 are related, and it is proposed that they are necessary for, or identical with, the onc genes of these viruses. These sequences would define a related class of transforming genes in avian tumor viruses that differs from the src genes of avian sarcoma viruses.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 221900      PMCID: PMC383444          DOI: 10.1073/pnas.76.4.1633

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  20 in total

1.  Genetic analysis of the defectiveness in strain MC29 avian leukosis virus.

Authors:  K Bister; P K Vogt
Journal:  Virology       Date:  1978-07-15       Impact factor: 3.616

2.  The defectiveness of Mill Hill 2, a carcinoma-inducing avian oncovirus.

Authors:  S S Hu; C Moscovici; P K Vogt
Journal:  Virology       Date:  1978-08       Impact factor: 3.616

3.  The terminal oligonucleotides of avian tumor virus RNAs are genetically linked.

Authors:  L H Wang; P H Duesberg; T Robins; H Yokota; P K Vogt
Journal:  Virology       Date:  1977-10-15       Impact factor: 3.616

4.  Defectiveness of avian myelocytomatosis virus MC29: isolation of long-term nonproducer cultures and analysis of virus-specific polypeptide synthesis.

Authors:  K Bister; M J Hayman; P K Vogt
Journal:  Virology       Date:  1977-10-15       Impact factor: 3.616

5.  The RNA of avian acute leukemia virus MC29.

Authors:  P H Duesberg; K Bister; P K Vogt
Journal:  Proc Natl Acad Sci U S A       Date:  1977-10       Impact factor: 11.205

6.  Specific RNA sequences and gene products of MC29 avian acute leukemia virus.

Authors:  P Mellon; A Pawson; K Bister; G S Martin; P H Duesberg
Journal:  Proc Natl Acad Sci U S A       Date:  1978-12       Impact factor: 11.205

7.  Nucleotide sequence relationships between the genomes of an endogenous and an exogenous avian tumor virus.

Authors:  J M Coffin; M Champion; F Chabot
Journal:  J Virol       Date:  1978-12       Impact factor: 5.103

8.  RNA species obtained from clonal lines of avian sarcoma and from avian leukosis virus.

Authors:  P H Duesberg; P K Vogt
Journal:  Virology       Date:  1973-07       Impact factor: 3.616

9.  Differences between the ribonucleic acids of transforming and nontransforming avian tumor viruses.

Authors:  P H Duesberg; P K Vogt
Journal:  Proc Natl Acad Sci U S A       Date:  1970-12       Impact factor: 11.205

10.  Component of strain MC29 avian leukosis virus with the property of defectiveness.

Authors:  R Ishizaki; A J Langlois; J Chabot; J W Beard
Journal:  J Virol       Date:  1971-12       Impact factor: 5.103

View more
  51 in total

Review 1.  MYC and metabolism on the path to cancer.

Authors:  Annie L Hsieh; Zandra E Walton; Brian J Altman; Zachary E Stine; Chi V Dang
Journal:  Semin Cell Dev Biol       Date:  2015-08-12       Impact factor: 7.727

Review 2.  An overview of MYC and its interactome.

Authors:  Maralice Conacci-Sorrell; Lisa McFerrin; Robert N Eisenman
Journal:  Cold Spring Harb Perspect Med       Date:  2014-01-01       Impact factor: 6.915

3.  MC29 virus-coded protein occurs as monomers and dimers in transformed cells.

Authors:  J P Bader; D A Ray
Journal:  J Virol       Date:  1985-02       Impact factor: 5.103

4.  Molecular cloning of proviral DNA and structural analysis of the transduced myc oncogene of avian oncovirus CMII.

Authors:  N Walther; R Lurz; T Patschinsky; H W Jansen; K Bister
Journal:  J Virol       Date:  1985-05       Impact factor: 5.103

Review 5.  Therapeutic strategies to inhibit MYC.

Authors:  Michael R McKeown; James E Bradner
Journal:  Cold Spring Harb Perspect Med       Date:  2014-10-01       Impact factor: 6.915

6.  Envelope gene sequences which encode the gp52 protein of spleen focus-forming virus are required for the induction of erythroid cell proliferation.

Authors:  D L Linemeyer; J G Menke; S K Ruscetti; L H Evans; E M Scolnick
Journal:  J Virol       Date:  1982-07       Impact factor: 5.103

7.  c-Myc and cancer metabolism.

Authors:  Donald M Miller; Shelia D Thomas; Ashraful Islam; David Muench; Kara Sedoris
Journal:  Clin Cancer Res       Date:  2012-10-15       Impact factor: 12.531

8.  Avian erythroblastosis virus produces two mRNA's.

Authors:  S M Anderson; W S Hayward; B G Neel; H Hanafusa
Journal:  J Virol       Date:  1980-12       Impact factor: 5.103

9.  Snyder-Theilen feline sarcoma virus P85 contains a single phosphotyrosine acceptor site recognized by its associated protein kinase.

Authors:  J Blomberg; W J Van de Ven; F H Reynolds; R P Nalewaik; J R Stephenson
Journal:  J Virol       Date:  1981-06       Impact factor: 5.103

Review 10.  SGF29 and Sry pathway in hepatocarcinogenesis.

Authors:  Nobuya Kurabe; Shigekazu Murakami; Fumio Tashiro
Journal:  World J Biol Chem       Date:  2015-08-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.